Proposed Substances To Be Evaluated for Set 22 Toxicological Profiles, 60673-60677 [E7-21018]
Download as PDF
<![CDATA[
mstockstill on PROD1PC66 with NOTICES
Federal Register / Vol. 72, No. 206 / Thursday, October 25, 2007 / Notices
Section 615(d) of the Fair Credit
Reporting Act (‘‘FCRA’’), 15 U.S.C.
1681m(d)(1), requires any person who
uses a consumer report in order to make
an unsolicited firm offer of credit or
insurance to a consumer to provide with
each written solicitation a clear and
conspicuous statement that:
(A) information contained in the
consumer’s consumer report was
used in connection with the
transaction; (B) the consumer
received the offer of credit or
insurance because the consumer
satisfied the criteria for credit
worthiness or insurability under
which the consumer was selected
for the offer; (C) if applicable, the
credit or insurance may not be
extended if, after the consumer
responds to the offer, the consumer
does not meet the criteria used to
select the consumer for the offer or
any applicable criteria bearing on
credit worthiness or insurability or
does not furnish any required
collateral; (D) the consumer has a
right to prohibit information
contained in the consumer’s file
with any consumer reporting
agency from being used in
connection with any credit or
insurance transaction that is not
initiated by the consumer; and (E)
the consumer may exercise the right
referred to in subparagraph (D) by
notifying a notification system
established under section 604(e) [of
the FCRA].
Section 615(d)(1) of the FCRA, 15
U.S.C. 1681m(d)(1).
The Fair and Accurate Credit
Transactions Act of 2003, Pub. L. 108159, 117 Stat. 1952 (‘‘FACT Act’’) was
signed into law on December 4, 2003.
Section 213(a) of the FACT Act
amended FCRA Section 615(d) to
require that the statement mandated by
Section 615(d) ‘‘be presented in such
format and in such type size and
manner as to be simple and easy to
understand, as established by the
Commission, by rule, in consultation
with the Federal banking agencies and
the National Credit Union
Administration.’’ The Commission
published the Final Rule implementing
this provision in the Federal Register on
January 31, 2005, and the Rule became
effective on August 1, 2005.
The Rule adopted a ‘‘layered’’ notice
approach that requires a short, simple,
and easy-to-understand statement of
consumers’ opt-out rights on the first
page of the prescreened solicitation,
along with a longer statement
containing additional details elsewhere
in the solicitation. Specifically, the Rule
requires that a short notice be placed on
VerDate Aug<31>2005
17:26 Oct 24, 2007
Jkt 214001
the front side of the first page of the
principal promotional document in the
solicitation, or, if provided
electronically, on the same page and in
close proximity to the principal
marketing message. The Rule specifies
that the type size be larger than the type
size of the principal text on the same
page, but in no event smaller than 12point type. If the notice is provided by
electronic means, the entity providing it
must take reasonable steps to ensure
that the type size is larger than the type
size of the principal text on the same
page. The Rule further provides that the
long notice that appears elsewhere in
the solicitation be in a type size that is
no smaller than the type size of the
principal text on the same page, but in
no event smaller than 8-point type. The
long notice must begin with the heading
‘‘PRESCREEN & OPT-OUT NOTICE,’’
which must be in capital letters and
underlined, set apart from other text on
the page, and in a type style that is
distinct from the principal type style
used on the same page. The Rule also
includes model notices in English and
Spanish.
Burden statement:
Estimated total annual hours burden:
1,000 to 1,500 hours (rounded to the
nearest thousand).
Based on public comments received
in response to the Commission’s 2004
Notice of Proposed Rulemaking,3 when
issuing the final Rule, the Commission
estimated that the annual burden to
industry would be between 43,600 and
45,600 hours.4 This estimate was
comprised of 500 to 750 companies each
spending 8 hours to revise an existing
solicitation, plus 100 companies each
needing an additional 396 hours to
revise multiple solicitations ((500
companies x 8 burden hours + 39,600
burden hours = 43,600 burden hours);
(750 companies x 8 burden hours +
39,600 burden hours = 45,600 burden
hours)).5 The Commission further
estimated that the total annual cost to
industry would be between $1,157,894
and $1,213,329.6
69 FR 58861 (Oct. 1, 2004).
70 FR 5022 (Jan. 31, 2005).
5 The Commission estimated that each of the 100
companies would revise 99 additional solicitations
and incur 4 hours of burden per solicitation (100
companies x 99 solicitations x 4 hours of burden
= 39,600 burden hours).
6 This estimate was based on Bureau of Labor
Statistics data (as of July, 2002), as follows: 2 hours
of managerial/professional time at $31.55 per hour;
plus 6 hours of skilled technical labor at $26.44 per
hour; multiplied by 500 and 750 companies, for a
total of $110,870 and $166,305, respectively. These
sums were added to $1,047,024 (39,600 hours of
skilled technical labor at $26.44 per hour) for
revising multiple solicitations.
3
4
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
60673
The requirements of the Rule have not
changed since OMB’s 2004 approval of
the final Rule. The previous estimates
included a one-time burden to
reprogram and update systems to revise
existing notices and to re-format
solicitations to comply with the Rule.
Because the Rule has been in effect
since August 1, 2005, covered entities
have already incurred the one-time costs
of transitioning to compliant notice
formats. Accordingly, the annual PRArelated burden associated with the Rule
is now reduced. FTC staff believes that
the primary cost of continuing to
comply with the Rule is limited to any
legal review each entity determines is
necessary to remain in compliance.
FTC staff continues to estimate that
between 500 and 750 entities make
prescreened solicitations. Because no
additional revision or reformatting is
necessary, however, staff has lowered
the estimate of the burden hours to
approximately 2 hours (one quarter of
one business day), rather than the
estimated 8 hours that was the estimate
to revise and reformat solicitations
when the Rule was promulgated.
Accordingly, the total annual burden is
between 1,000 and 1,500 hours (500 to
750 entities x 2 hours of annual burden).
FTC staff assumes that in-house legal
counsel will handle most of the
compliance review and has applied an
average hourly wage of $250/hour for
their labor. Accordingly, the total cost
for all affected entities would be
between $250,000 and $375,000 (1000
to 1,500 burden hours x $250 per hour
of legal review time).
John D. Graubert,
Acting General Counsel.
[FR Doc. E7–21067 Filed 10–24–07: 8:45 am]
BILLING CODE 6750–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[ATSDR–235]
Proposed Substances To Be Evaluated
for Set 22 Toxicological Profiles
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Request for comments on the
proposed substances to be evaluated for
Set 22 toxicological profiles.
AGENCY:
SUMMARY: This notice announces the list
of proposed substances that will be
evaluated for CERCLA Set 22
E:\FR\FM\25OCN1.SGM
25OCN1
60674
Federal Register / Vol. 72, No. 206 / Thursday, October 25, 2007 / Notices
toxicological profile development.
ATSDR’s Division of Toxicology and
Environmental Medicine is soliciting
public nominations from the list of
proposed substances to be evaluated for
toxicological profile development.
ATSDR also will consider the
evaluation of any additional substances
that may have public health
implications.
DATES: Nominations must be submitted
within 30 days of the publication of this
notice. The 30-day period begins
October 26th, 2007 and ends November
26th, 2007.
ADDRESSES: Nominations may be
submitted electronically, by mail, or by
facsimile. Refer to the section
Submission of Nominations (below) for
specific addresses and/or the facsimile
number.
FOR FURTHER INFORMATION CONTACT:
Contact Commander Jessilynn B. Taylor,
Division of Toxicology and
Environmental Medicine, Agency for
Toxic Substances and Disease Registry,
Mailstop F–32, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, telephone (770)
488–3313.
The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) [42
U.S.C. 9601 et seq.] by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) with regard to hazardous
substances that are most commonly
found at facilities on the CERCLA
National Priorities List (NPL). Among
these statutory requirements is a
mandate for the Administrator of
ATSDR to prepare toxicological profiles
for each substance included on the
Priority List of Hazardous Substances.
This list has identified 275 hazardous
substances that ATSDR and EPA
determined pose the most significant
potential threat to human health. The
availability of the revised list of the 275
priority substances was announced in
SUPPLEMENTARY INFORMATION:
the Federal Register on December 7,
2005 (70 FR 702840). For prior versions
of the list of substances, see Federal
Register notices dated April 17, 1987
(52 FR 12866); October 20, 1988 (53 FR
41280); October 26, 1989 (54 FR 43619);
October 17, 1990 (55 FR 42067); October
17, 1991 (56 FR 52166); October 28,
1992 (57 FR 48801); February 28, 1994
(59 FR 9486); April 29, 1996 (61 FR
18744; November 17, 1997 (62 FR
61332); October 21, 1999 (64 FR 56792);
October 25, 2001 (66 FR 54014) and
November 7, 2003 (68 FR 63098).
Proposed Substances To Be Evaluated
for Set 22 Toxicological Profiles
Each year, ATSDR develops a list of
priority substances that will be
evaluated for toxicological profile
development. This list was compiled,
on the basis of ATSDR’s Priority List of
Hazardous Substances, with
consideration of the amount of
relevance of newly published scientific
literature. The following 73 substances
will be evaluated:
Substance name
1 ..........
2 ..........
3 ..........
mstockstill on PROD1PC66 with NOTICES
4 ..........
5 ..........
CAS No.
PERFLUOROOCTANOIC ACID ........................................................................................................................................
PERFLUOROCYL SULFONATES .....................................................................................................................................
MERCURY .........................................................................................................................................................................
METHYLMERCURY ...........................................................................................................................................................
MERCURIC CHLORIDE ....................................................................................................................................................
POLYCHLORINATED BIPHENYLS ...................................................................................................................................
AROCLOR 1254 ................................................................................................................................................................
AROCLOR 1260 ................................................................................................................................................................
AROCLOR 1248 ................................................................................................................................................................
AROCLOR 1242 ................................................................................................................................................................
AROCLOR ..........................................................................................................................................................................
AROCLOR 1221 ................................................................................................................................................................
AROCLOR 1016 ................................................................................................................................................................
AROCLOR 1232 ................................................................................................................................................................
AROCLOR 1240 ................................................................................................................................................................
TETRACHLOROBIPHENYL ..............................................................................................................................................
CADMIUM ..........................................................................................................................................................................
POLYCYCLIC AROMATIC HYDROCARBONS ................................................................................................................
BENZO(A)PYRENE ...........................................................................................................................................................
BENZO(B)FLUORANTHENE .............................................................................................................................................
DIBENZO(A,H)ANTHRACENE ..........................................................................................................................................
BENZO(A)ANTHRACENE .................................................................................................................................................
BENZO(K)FLUORANTHENE .............................................................................................................................................
BENZOFLUORANTHENE ..................................................................................................................................................
FLUORANTHENE ..............................................................................................................................................................
CHRYSENE .......................................................................................................................................................................
ACENAPHTHENE ..............................................................................................................................................................
INDENO(1,2,3-CD)PYRENE ..............................................................................................................................................
BENZOPYRENE ................................................................................................................................................................
PHENANTHRENE ..............................................................................................................................................................
PYRENE .............................................................................................................................................................................
FLUORENE ........................................................................................................................................................................
ANTHRACENE ...................................................................................................................................................................
BENZO(A)FLUORANTHENE .............................................................................................................................................
BENZO(GHI)PERYLENE ...................................................................................................................................................
ACENAPHTHYLENE .........................................................................................................................................................
BENZO(J)FLUORANTHENE .............................................................................................................................................
BENZO(E)PYRENE ...........................................................................................................................................................
BENZOPERYLENE ............................................................................................................................................................
BENZO(B)ANTHRACENE .................................................................................................................................................
DIBENZ(A,J)ANTHRACENE ..............................................................................................................................................
BENZO(GHI)FLUORANTHENE .........................................................................................................................................
1-METHYLPYRENE ...........................................................................................................................................................
VerDate Aug<31>2005
17:26 Oct 24, 2007
Jkt 214001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\25OCN1.SGM
25OCN1
(1)
(1)
007439–97–6
022967–92–6
007487–94–7
001336–36–3
011097–69–1
011096–82–5
012672–29–6
053469–21–9
012767–79–2
011104–28–2
012674–11–2
011141–16–5
071328–89–7
026914–33–0
007440–43–9
130498–29–2
000050–32–8
000205–99–2
000053–70–3
000056–55–3
000207–08–9
056832–73–6
000206–44–0
000218–01–9
000083–32–9
000193–39–5
073467–76–2
000085–01–8
000129–00–0
000086–73–7
000120–12–7
000203–33–8
000191–24–2
000208–96–8
000205–82–3
000192–97–2
011057–45–7
000092–24–0
000224–41–9
000203–12–3
002381–21–7
Federal Register / Vol. 72, No. 206 / Thursday, October 25, 2007 / Notices
60675
Substance name
6 ..........
7 ..........
8 ..........
9 ..........
10 ........
11 ........
12 ........
13 ........
14
15
16
17
18
19
20
21
........
........
........
........
........
........
........
........
22 ........
23 ........
24 ........
25 ........
mstockstill on PROD1PC66 with NOTICES
26
27
28
29
30
........
........
........
........
........
31
32
33
34
35
36
37
........
........
........
........
........
........
........
CAS No.
CHLOROFORM .................................................................................................................................................................
DDT, P,P′- ..........................................................................................................................................................................
DDE, P,P′- ..........................................................................................................................................................................
DDD, P,P′- .........................................................................................................................................................................
DDT, O,P′- .........................................................................................................................................................................
DDD, O,P′- .........................................................................................................................................................................
DDE, O,P′- .........................................................................................................................................................................
TRICHLOROETHYLENE ...................................................................................................................................................
IELDRIN .............................................................................................................................................................................
ALDRIN ..............................................................................................................................................................................
CHROMIUM, HEXAVALENT .............................................................................................................................................
CHROMIUM(VI) OXIDE .....................................................................................................................................................
CHROMIUM .......................................................................................................................................................................
CHROMIUM TRIOXIDE .....................................................................................................................................................
CHROMIUM, TRIVALENT .................................................................................................................................................
CHLORDANE .....................................................................................................................................................................
CIS-CHLORDANE ..............................................................................................................................................................
TRANS-CHLORDANE .......................................................................................................................................................
OXYCHLORDANE .............................................................................................................................................................
GAMMA-CHLORDENE ......................................................................................................................................................
CHLORDANE, TECHNICAL ..............................................................................................................................................
ALPHA-CHLORDENE ........................................................................................................................................................
NONACHLOR, TRANS- .....................................................................................................................................................
NONACHLOR, CIS- ...........................................................................................................................................................
CHLORDENE .....................................................................................................................................................................
HEXACHLOROBUTADIENE ..............................................................................................................................................
COAL TAR CREOSOTE ....................................................................................................................................................
COAL TARS .......................................................................................................................................................................
COAL TAR PITCH .............................................................................................................................................................
BENZIDINE ........................................................................................................................................................................
TOXAPHENE .....................................................................................................................................................................
TETRACHLOROETHYLENE .............................................................................................................................................
1,2-DIBROMOETHANE .....................................................................................................................................................
DISULFOTON ....................................................................................................................................................................
3,3′-DICHLOROBENZIDINE ..............................................................................................................................................
BERYLLIUM .......................................................................................................................................................................
ENDRIN ..............................................................................................................................................................................
ENDRIN KETONE ..............................................................................................................................................................
ENDRIN ALDEHYDE .........................................................................................................................................................
1,2-DIBROMO–3-CHLOROPROPANE ..............................................................................................................................
DIBROMOCHLOROPROPANE .........................................................................................................................................
PENTACHLOROPHENOL .................................................................................................................................................
DI-N-BUTYL PHTHALATE .................................................................................................................................................
ENDOSULFAN SULFATE .................................................................................................................................................
ENDOSULFAN ...................................................................................................................................................................
ENDOSULFAN, ALPHA .....................................................................................................................................................
ENDOSULFAN, BETA .......................................................................................................................................................
METHOXYCHLOR .............................................................................................................................................................
METHANE ..........................................................................................................................................................................
TOLUENE ..........................................................................................................................................................................
2-HEXANONE ....................................................................................................................................................................
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN ...................................................................................................................
HEXACHLORODIBENZO-P-DIOXIN .................................................................................................................................
HEPTACHLORODIBENZO-P-DIOXIN ...............................................................................................................................
TETRACHLORODIBENZO-P-DIOXIN ...............................................................................................................................
PENTACHLORODIBENZO-P-DIOXIN ...............................................................................................................................
1,2,3,4,6,7,8-HEPTACHLORODIBENZO-P-DIOXIN ..........................................................................................................
OCTACHLORODIBENZO-P-DIOXIN .................................................................................................................................
1,2,3,6,7,8-HEXACHLORODIBENZO-P-DIOXIN ...............................................................................................................
1,2,3,4,7,8-HEXACHLORODIBENZO-P-DIOXIN ...............................................................................................................
1,2,3,7,8,9-HEXACHLORODIBENZO-P-DIOXIN ...............................................................................................................
1,2,3,7,8-PENTACHLORODIBENZO-P-DIOXIN ................................................................................................................
DI(2-ETHYLHEXYL)PHTHALATE ......................................................................................................................................
1,1-DICHLOROETHENE ....................................................................................................................................................
METHYLENE CHLORIDE ..................................................................................................................................................
2,4,6-TRINITROTOLUENE ................................................................................................................................................
BROMODICHLOROETHANE ............................................................................................................................................
1,2-DICHLOROETHANE ....................................................................................................................................................
2,4,6-TRICHLOROPHENOL ..............................................................................................................................................
TETRACHLOROPHENOL .................................................................................................................................................
2,4-DICHLOROPHENOL ...................................................................................................................................................
2,4,5-TRICHLOROPHENOL ..............................................................................................................................................
2-CHLOROPHENOL ..........................................................................................................................................................
2,3,4,5-TETRACHLOROPHENOL .....................................................................................................................................
000067–66–3
000050–29–3
000072–55–9
000072–54–8
000789–02–6
000053–19–0
003424–82–6
000079–01–6
000060–57–1
000309–00–2
018540–29–9
001333–82–0
007440–47–3
007738–94–5
016065–83–1
000057–74–9
005103–71–9
005103–74–2
027304–13–8
056641–38–4
012789–03–6
056534–02–2
039765–80–5
005103–73–1
003734–48–3
000087–68–3
008001–58–9
008007–45–2
065996–93–2
000092–87–5
008001–35–2
000127–18–4
000106–93–4
000298–04–4
000091–94–1
007440–41–7
000072–20–8
053494–70–5
007421–93–4
000096–12–8
067708–83–2
000087–86–5
000084–74–2
001031–07–8
000115–29–7
000959–98–8
033213–65–9
000072–43–5
000074–82–8
000108–88–3
000591–78–6
001746–01–6
034465–46–8
037871–00–4
041903–57–5
036088–22–9
035822–46–9
003268–87–9
057653–85–7
039227–28–6
019408–74–3
040321–76–4
000117–81–7
000075–35–4
000075–09–2
000118–96–7
000683–53–4
000107–06–2
000088–06–2
025167–83–3
000120–83–2
000095–95–4
000095–57–8
004901–51–3
VerDate Aug<31>2005
17:26 Oct 24, 2007
Jkt 214001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\25OCN1.SGM
25OCN1
60676
Federal Register / Vol. 72, No. 206 / Thursday, October 25, 2007 / Notices
Substance name
38 ........
39 ........
40 ........
41 ........
42 ........
43 ........
44 ........
45 ........
46 ........
47 ........
48 ........
49 ........
50 ........
........
........
........
........
........
56
57
58
59
60
61
62
63
64
65
66
67
mstockstill on PROD1PC66 with NOTICES
51
52
53
54
55
........
........
........
........
........
........
........
........
........
........
........
........
68
69
70
71
72
73
........
........
........
........
........
........
(1)
CAS No.
2,3,5,6-TETRACHLOROPHENOL .....................................................................................................................................
2,3,4,6-TETRACHLOROPHENOL .....................................................................................................................................
4-CHLOROPHENOL ..........................................................................................................................................................
CHLOROPHENOL .............................................................................................................................................................
2,4-DINITROPHENOL ........................................................................................................................................................
BIS(2-CHLOROETHYL) ETHER ........................................................................................................................................
ASBESTOS ........................................................................................................................................................................
CHRYSOTILE ASBESTOS ................................................................................................................................................
AMOSITE ASBESTOS .......................................................................................................................................................
HEXACHLOROBENZENE .................................................................................................................................................
RADIUM–226 .....................................................................................................................................................................
RADIUM .............................................................................................................................................................................
RADIUM–228 .....................................................................................................................................................................
RADIUM–224 .....................................................................................................................................................................
2,4-DINITROTOLUENE .....................................................................................................................................................
DINITROTOLUENE ............................................................................................................................................................
2,6-DINITROTOLUENE .....................................................................................................................................................
ETHION ..............................................................................................................................................................................
THORIUM ...........................................................................................................................................................................
THORIUM–230 ...................................................................................................................................................................
THORIUM–228 ...................................................................................................................................................................
4,6-DINITRO-O-CRESOL ..................................................................................................................................................
RADON ..............................................................................................................................................................................
RADON–222 ......................................................................................................................................................................
RADON–220 ......................................................................................................................................................................
CHLOROBENZENE ...........................................................................................................................................................
N-NITROSODI-N-PROPYLAMINE .....................................................................................................................................
MANGANESE ....................................................................................................................................................................
MANGANESE DIOXIDE ....................................................................................................................................................
POLONIUM–210 ................................................................................................................................................................
LEAD–210 ..........................................................................................................................................................................
CHLORPYRIFOS ...............................................................................................................................................................
NEPTUNIUM–237 ..............................................................................................................................................................
CHLORDECONE ...............................................................................................................................................................
MIREX ................................................................................................................................................................................
S,S,S-TRIBUTYL PHOSPHOROTRITHIOATE ..................................................................................................................
BROMINE ...........................................................................................................................................................................
1,2,3-TRICHLOROBENZENE ............................................................................................................................................
DICOFOL ...........................................................................................................................................................................
PARATHION ......................................................................................................................................................................
TRICHLOROFLUOROETHANE .........................................................................................................................................
TRIFLURALIN ....................................................................................................................................................................
4,4′-METHYLENEBIS(2-CHLOROANILINE) ......................................................................................................................
PENTACHLOROBENZENE ...............................................................................................................................................
1,1-DICHLOROETHANE ....................................................................................................................................................
1,1,2-TRICHLOROETHANE ..............................................................................................................................................
1,2,3,4,6,7,8,9-OCTACHLORODIBENZOFURAN .............................................................................................................
HEPTACHLORODIBENZOFURAN ....................................................................................................................................
2,3,4,7,8-PENTACHLORODIBENZOFURAN ....................................................................................................................
HEXACHLORODIBENZOFURAN ......................................................................................................................................
PENTACHLORODIBENZOFURAN ....................................................................................................................................
2,3,7,8-TETRACHLORODIBENZOFURAN ........................................................................................................................
DIBENZOFURANS, CHLORINATED .................................................................................................................................
1,2,3,4,6,7,8-HEPTACHLORODIBENZOFURAN ..............................................................................................................
1,2,3,7,8,9-HEXACHLORODIBENZOFURAN ....................................................................................................................
TETRACHLORODIBENZOFURAN ....................................................................................................................................
1,2,3,6,7,8-HEXACHLORODIBENZOFURAN ....................................................................................................................
1,2,3,4,7,8-HEXACHLORODIBENZOFURAN ....................................................................................................................
2,3,4,6,7,8-HEXACHLORODIBENZOFURAN ....................................................................................................................
1,2,3,7,8-PENTACHLORODIBENZOFURAN ....................................................................................................................
1,2,3,4,7,8,9-HEPTACHLORODIBENZOFURAN ..............................................................................................................
TRICHLOROETHANE ........................................................................................................................................................
HEXACHLOROCYCLOPENTADIENE ...............................................................................................................................
1,2-DIPHENYLHYDRAZINE ..............................................................................................................................................
NANOMATERIALS .............................................................................................................................................................
VANADIUM ........................................................................................................................................................................
FORMALDEHYDE .............................................................................................................................................................
000935–95–5
000058–90–2
000106–48–9
025167–80–0
000051–28–5
000111–44–4
001332–21–4
012001–29–5
012172–73–5
000118–74–1
013982–63–3
007440–14–4
015262–20–1
013233–32–4
000121–14–2
025321–14–6
000606–20–2
000563–12–2
007440–29–1
014269–63–7
014274–82–9
000534–52–1
010043–92–2
014859–67–7
022481–48–7
000108–90–7
000621–64–7
007439–96–5
001313–13–9
013981–52–7
014255–04–0
002921–88–2
013994–20–2
000143–50–0
002385–85–5
000078–48–8
007726–95–6
000087–61–6
000115–32–2
000056–38–2
027154–33–2
001582–09–8
000101–14–4
000608–93–5
000075–34–3
000079–00–5
039001–02–0
038998–75–3
057117–31–4
055684–94–1
030402–15–4
051207–31–9
042934–53–2
067562–39–4
072918–21–9
030402–14–3
057117–44–9
070648–26–9
060851–34–5
057117–41–6
055673–89–7
025323–89–1
000077–47–4
000122–66–7
........................
007440–62–2
000050–00–0
Various.
VerDate Aug<31>2005
17:26 Oct 24, 2007
Jkt 214001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\25OCN1.SGM
25OCN1
Federal Register / Vol. 72, No. 206 / Thursday, October 25, 2007 / Notices
Submission of Nominations for the
Evaluation Set 22
Proposed Substances: Today’s notice
also invites voluntary public
nominations for substances not listed in
this notice. Nominations are most useful
if they include the nominator, including
full name, title, affiliation, email
address, and telephone number.
ATSDR will evaluate all data and
information associated with nominated
substances and will determine the final
list of substances that will be chosen for
toxicological profile development.
Substances will be chosen according to
ATSDR’s specific guidelines for
selection, found in the Selection Criteria
announced in the Federal Register on
May 7th, 1993 (87 FR 27288).
Please submit nominations by one of
the following methods:
• E-mail: jxt1@cdc.gov.
• Fax: 770.488.4178.
• Mail: CDR Jessilynn Taylor, 1600
Clifton Rd, NE., MS F32, Atlanta, GA,
30333.
Please ensure that your comments are
submitted within the specified
nomination period. Nominations
received after the closing date will be
marked as late and may be considered
only if time permits.
Components; Notification of Consignees
and Transfusion Recipients Receiving
Blood and Blood Components at
Increased Risk of Transmitting HCV
Infection (‘‘Lookback’’)’’ has been
approved by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 24, 2007 (72
FR 48766), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0610. The
approval expires on October 31, 2010. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
Dated: October 19, 2007.
Ken Rose,
Director, Office of Policy, Planning and
Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. E7–21018 Filed 10–24–07; 8:45 am]
Dated: October 19, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–21055 Filed 10–24–07; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–01–S
Food and Drug Administration
Food and Drug Administration
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Guidance for Industry on Continuous
Marketing Applications: Pilot—
Scientific Feedback and Interactions
During Development of Fast Track
Products Under the Prescription Drug
User Fee Act
[Docket No. 2006N–0278]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
CGMP for Blood and Blood
Components; Notification of
Consignees and Transfusion
Recipients Receiving Blood and Blood
Components at Increased Risk of
Transmitting HCV Infection
(‘‘Lookback’’)
mstockstill on PROD1PC66 with NOTICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘CGMP for Blood and Blood
VerDate Aug<31>2005
17:26 Oct 24, 2007
Jkt 214001
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘ Guidance for Industry on Continuous
Marketing Applications: Pilot—
Scientific Feedback and Interactions
During Development of Fast Track
Products Under the Prescription Drug
User Fee Act‘‘ has been approved by the
PO 00000
Frm 00061
Fmt 4703
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Karen L. Nelson, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4816.
SUPPLEMENTARY INFORMATION: In the
Federal Register of May 21, 2007 (72 FR
28495), the agency announced that the
proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0518. The
approval expires on September 30,
2010. A copy of the supporting
statement for this information collection
is available on the Internet at https://
www.fda.gov/ohrms/dockets.
Dated: October 19, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–21056 Filed 10–24–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. 1999N–2337 (formerly Docket
No. 99N–2337)]
60677
Sfmt 4703
[Docket No. 2007N-0390]
User Fee Program for Advisory Review
of Direct-to-Consumer Television
Advertisements for Prescription Drug
and Biological Products; Request for
Notification of Participation and
Number of Advertisements for Review
AGENCY:
Food and Drug Administration,
HHS.
Notice; request for notification
of participation.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is issuing this
notice to explain the new direct-toconsumer (DTC) user fee program (DTC
user fee program) established by the
Food and Drug Administration
Amendments Act of 2007 (FDAAA) and,
as required by the new law, to ask
companies to notify FDA within 30
calendar days if they intend to
participate in the DTC user fee program
during fiscal year (FY) 2008 and, if they
do plan to participate, to identify the
number of DTC television
advertisements for prescription drug
and biological products they plan to
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 72, Number 206 (Thursday, October 25, 2007)]
[Notices]
[Pages 60673-60677]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21018]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[ATSDR-235]
Proposed Substances To Be Evaluated for Set 22 Toxicological
Profiles
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (HHS).
ACTION: Request for comments on the proposed substances to be evaluated
for Set 22 toxicological profiles.
-----------------------------------------------------------------------
SUMMARY: This notice announces the list of proposed substances that
will be evaluated for CERCLA Set 22
[[Page 60674]]
toxicological profile development. ATSDR's Division of Toxicology and
Environmental Medicine is soliciting public nominations from the list
of proposed substances to be evaluated for toxicological profile
development. ATSDR also will consider the evaluation of any additional
substances that may have public health implications.
DATES: Nominations must be submitted within 30 days of the publication
of this notice. The 30-day period begins October 26th, 2007 and ends
November 26th, 2007.
ADDRESSES: Nominations may be submitted electronically, by mail, or by
facsimile. Refer to the section Submission of Nominations (below) for
specific addresses and/or the facsimile number.
FOR FURTHER INFORMATION CONTACT: Contact Commander Jessilynn B. Taylor,
Division of Toxicology and Environmental Medicine, Agency for Toxic
Substances and Disease Registry, Mailstop F-32, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, telephone (770) 488-3313.
SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization
Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA
or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain
requirements for ATSDR and the U.S. Environmental Protection Agency
(EPA) with regard to hazardous substances that are most commonly found
at facilities on the CERCLA National Priorities List (NPL). Among these
statutory requirements is a mandate for the Administrator of ATSDR to
prepare toxicological profiles for each substance included on the
Priority List of Hazardous Substances. This list has identified 275
hazardous substances that ATSDR and EPA determined pose the most
significant potential threat to human health. The availability of the
revised list of the 275 priority substances was announced in the
Federal Register on December 7, 2005 (70 FR 702840). For prior versions
of the list of substances, see Federal Register notices dated April 17,
1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989
(54 FR 43619); October 17, 1990 (55 FR 42067); October 17, 1991 (56 FR
52166); October 28, 1992 (57 FR 48801); February 28, 1994 (59 FR 9486);
April 29, 1996 (61 FR 18744; November 17, 1997 (62 FR 61332); October
21, 1999 (64 FR 56792); October 25, 2001 (66 FR 54014) and November 7,
2003 (68 FR 63098).
Proposed Substances To Be Evaluated for Set 22 Toxicological Profiles
Each year, ATSDR develops a list of priority substances that will
be evaluated for toxicological profile development. This list was
compiled, on the basis of ATSDR's Priority List of Hazardous
Substances, with consideration of the amount of relevance of newly
published scientific literature. The following 73 substances will be
evaluated:
------------------------------------------------------------------------
Substance name CAS No.
------------------------------------------------------------------------
1..................... PERFLUOROOCTANOIC ACID.......... (1)
PERFLUOROCYL SULFONATES......... (1)
2..................... MERCURY......................... 007439-97-6
METHYLMERCURY................... 022967-92-6
MERCURIC CHLORIDE............... 007487-94-7
3..................... POLYCHLORINATED BIPHENYLS....... 001336-36-3
AROCLOR 1254.................... 011097-69-1
AROCLOR 1260.................... 011096-82-5
AROCLOR 1248.................... 012672-29-6
AROCLOR 1242.................... 053469-21-9
AROCLOR......................... 012767-79-2
AROCLOR 1221.................... 011104-28-2
AROCLOR 1016.................... 012674-11-2
AROCLOR 1232.................... 011141-16-5
AROCLOR 1240.................... 071328-89-7
TETRACHLOROBIPHENYL............. 026914-33-0
4..................... CADMIUM......................... 007440-43-9
5..................... POLYCYCLIC AROMATIC HYDROCARBONS 130498-29-2
BENZO(A)PYRENE.................. 000050-32-8
BENZO(B)FLUORANTHENE............ 000205-99-2
DIBENZO(A,H)ANTHRACENE.......... 000053-70-3
BENZO(A)ANTHRACENE.............. 000056-55-3
BENZO(K)FLUORANTHENE............ 000207-08-9
BENZOFLUORANTHENE............... 056832-73-6
FLUORANTHENE.................... 000206-44-0
CHRYSENE........................ 000218-01-9
ACENAPHTHENE.................... 000083-32-9
INDENO(1,2,3-CD)PYRENE.......... 000193-39-5
BENZOPYRENE..................... 073467-76-2
PHENANTHRENE.................... 000085-01-8
PYRENE.......................... 000129-00-0
FLUORENE........................ 000086-73-7
ANTHRACENE...................... 000120-12-7
BENZO(A)FLUORANTHENE............ 000203-33-8
BENZO(GHI)PERYLENE.............. 000191-24-2
ACENAPHTHYLENE.................. 000208-96-8
BENZO(J)FLUORANTHENE............ 000205-82-3
BENZO(E)PYRENE.................. 000192-97-2
BENZOPERYLENE................... 011057-45-7
BENZO(B)ANTHRACENE.............. 000092-24-0
DIBENZ(A,J)ANTHRACENE........... 000224-41-9
BENZO(GHI)FLUORANTHENE.......... 000203-12-3
1-METHYLPYRENE.................. 002381-21-7
[[Page 60675]]
6..................... CHLOROFORM...................... 000067-66-3
7..................... DDT, P,P'-...................... 000050-29-3
DDE, P,P'-...................... 000072-55-9
DDD, P,P'-...................... 000072-54-8
DDT, O,P'-...................... 000789-02-6
DDD, O,P'-...................... 000053-19-0
DDE, O,P'-...................... 003424-82-6
8..................... TRICHLOROETHYLENE............... 000079-01-6
9..................... IELDRIN......................... 000060-57-1
ALDRIN.......................... 000309-00-2
10.................... CHROMIUM, HEXAVALENT............ 018540-29-9
CHROMIUM(VI) OXIDE.............. 001333-82-0
CHROMIUM........................ 007440-47-3
CHROMIUM TRIOXIDE............... 007738-94-5
CHROMIUM, TRIVALENT............. 016065-83-1
11.................... CHLORDANE....................... 000057-74-9
CIS-CHLORDANE................... 005103-71-9
TRANS-CHLORDANE................. 005103-74-2
OXYCHLORDANE.................... 027304-13-8
GAMMA-CHLORDENE................. 056641-38-4
CHLORDANE, TECHNICAL............ 012789-03-6
ALPHA-CHLORDENE................. 056534-02-2
NONACHLOR, TRANS-............... 039765-80-5
NONACHLOR, CIS-................. 005103-73-1
CHLORDENE....................... 003734-48-3
12.................... HEXACHLOROBUTADIENE............. 000087-68-3
13.................... COAL TAR CREOSOTE............... 008001-58-9
COAL TARS....................... 008007-45-2
COAL TAR PITCH.................. 065996-93-2
14.................... BENZIDINE....................... 000092-87-5
15.................... TOXAPHENE....................... 008001-35-2
16.................... TETRACHLOROETHYLENE............. 000127-18-4
17.................... 1,2-DIBROMOETHANE............... 000106-93-4
18.................... DISULFOTON...................... 000298-04-4
19.................... 3,3'-DICHLOROBENZIDINE.......... 000091-94-1
20.................... BERYLLIUM....................... 007440-41-7
21.................... ENDRIN.......................... 000072-20-8
ENDRIN KETONE................... 053494-70-5
ENDRIN ALDEHYDE................. 007421-93-4
22.................... 1,2-DIBROMO-3-CHLOROPROPANE..... 000096-12-8
DIBROMOCHLOROPROPANE............ 067708-83-2
23.................... PENTACHLOROPHENOL............... 000087-86-5
24.................... DI-N-BUTYL PHTHALATE............ 000084-74-2
25.................... ENDOSULFAN SULFATE.............. 001031-07-8
ENDOSULFAN...................... 000115-29-7
ENDOSULFAN, ALPHA............... 000959-98-8
ENDOSULFAN, BETA................ 033213-65-9
26.................... METHOXYCHLOR.................... 000072-43-5
27.................... METHANE......................... 000074-82-8
28.................... TOLUENE......................... 000108-88-3
29.................... 2-HEXANONE...................... 000591-78-6
30.................... 2,3,7,8-TETRACHLORODIBENZO-P- 001746-01-6
DIOXIN.
HEXACHLORODIBENZO-P-DIOXIN...... 034465-46-8
HEPTACHLORODIBENZO-P-DIOXIN..... 037871-00-4
TETRACHLORODIBENZO-P-DIOXIN..... 041903-57-5
PENTACHLORODIBENZO-P-DIOXIN..... 036088-22-9
1,2,3,4,6,7,8-HEPTACHLORODIBENZO- 035822-46-9
P-DIOXIN.
OCTACHLORODIBENZO-P-DIOXIN...... 003268-87-9
1,2,3,6,7,8-HEXACHLORODIBENZO-P- 057653-85-7
DIOXIN.
1,2,3,4,7,8-HEXACHLORODIBENZO-P- 039227-28-6
DIOXIN.
1,2,3,7,8,9-HEXACHLORODIBENZO-P- 019408-74-3
DIOXIN.
1,2,3,7,8-PENTACHLORODIBENZO-P- 040321-76-4
DIOXIN.
31.................... DI(2-ETHYLHEXYL)PHTHALATE....... 000117-81-7
32.................... 1,1-DICHLOROETHENE.............. 000075-35-4
33.................... METHYLENE CHLORIDE.............. 000075-09-2
34.................... 2,4,6-TRINITROTOLUENE........... 000118-96-7
35.................... BROMODICHLOROETHANE............. 000683-53-4
36.................... 1,2-DICHLOROETHANE.............. 000107-06-2
37.................... 2,4,6-TRICHLOROPHENOL........... 000088-06-2
TETRACHLOROPHENOL............... 025167-83-3
2,4-DICHLOROPHENOL.............. 000120-83-2
2,4,5-TRICHLOROPHENOL........... 000095-95-4
2-CHLOROPHENOL.................. 000095-57-8
2,3,4,5-TETRACHLOROPHENOL....... 004901-51-3
[[Page 60676]]
2,3,5,6-TETRACHLOROPHENOL....... 000935-95-5
2,3,4,6-TETRACHLOROPHENOL....... 000058-90-2
4-CHLOROPHENOL.................. 000106-48-9
CHLOROPHENOL.................... 025167-80-0
38.................... 2,4-DINITROPHENOL............... 000051-28-5
39.................... BIS(2-CHLOROETHYL) ETHER........ 000111-44-4
40.................... ASBESTOS........................ 001332-21-4
CHRYSOTILE ASBESTOS............. 012001-29-5
AMOSITE ASBESTOS................ 012172-73-5
41.................... HEXACHLOROBENZENE............... 000118-74-1
42.................... RADIUM-226...................... 013982-63-3
RADIUM.......................... 007440-14-4
RADIUM-228...................... 015262-20-1
RADIUM-224...................... 013233-32-4
43.................... 2,4-DINITROTOLUENE.............. 000121-14-2
DINITROTOLUENE.................. 025321-14-6
2,6-DINITROTOLUENE.............. 000606-20-2
44.................... ETHION.......................... 000563-12-2
45.................... THORIUM......................... 007440-29-1
THORIUM-230..................... 014269-63-7
THORIUM-228..................... 014274-82-9
46.................... 4,6-DINITRO-O-CRESOL............ 000534-52-1
47.................... RADON........................... 010043-92-2
RADON-222....................... 014859-67-7
RADON-220....................... 022481-48-7
48.................... CHLOROBENZENE................... 000108-90-7
49.................... N-NITROSODI-N-PROPYLAMINE....... 000621-64-7
50.................... MANGANESE....................... 007439-96-5
MANGANESE DIOXIDE............... 001313-13-9
51.................... POLONIUM-210.................... 013981-52-7
52.................... LEAD-210........................ 014255-04-0
53.................... CHLORPYRIFOS.................... 002921-88-2
54.................... NEPTUNIUM-237................... 013994-20-2
55.................... CHLORDECONE..................... 000143-50-0
MIREX........................... 002385-85-5
56.................... S,S,S-TRIBUTYL 000078-48-8
PHOSPHOROTRITHIOATE.
57.................... BROMINE......................... 007726-95-6
58.................... 1,2,3-TRICHLOROBENZENE.......... 000087-61-6
59.................... DICOFOL......................... 000115-32-2
60.................... PARATHION....................... 000056-38-2
61.................... TRICHLOROFLUOROETHANE........... 027154-33-2
62.................... TRIFLURALIN..................... 001582-09-8
63.................... 4,4'-METHYLENEBIS(2- 000101-14-4
CHLOROANILINE).
64.................... PENTACHLOROBENZENE.............. 000608-93-5
65.................... 1,1-DICHLOROETHANE.............. 000075-34-3
66.................... 1,1,2-TRICHLOROETHANE........... 000079-00-5
67.................... 1,2,3,4,6,7,8,9- 039001-02-0
OCTACHLORODIBENZOFURAN.
HEPTACHLORODIBENZOFURAN......... 038998-75-3
2,3,4,7,8- 057117-31-4
PENTACHLORODIBENZOFURAN.
HEXACHLORODIBENZOFURAN.......... 055684-94-1
PENTACHLORODIBENZOFURAN......... 030402-15-4
2,3,7,8-TETRACHLORODIBENZOFURAN. 051207-31-9
DIBENZOFURANS, CHLORINATED...... 042934-53-2
1,2,3,4,6,7,8- 067562-39-4
HEPTACHLORODIBENZOFURAN.
1,2,3,7,8,9- 072918-21-9
HEXACHLORODIBENZOFURAN.
TETRACHLORODIBENZOFURAN......... 030402-14-3
1,2,3,6,7,8- 057117-44-9
HEXACHLORODIBENZOFURAN.
1,2,3,4,7,8- 070648-26-9
HEXACHLORODIBENZOFURAN.
2,3,4,6,7,8- 060851-34-5
HEXACHLORODIBENZOFURAN.
1,2,3,7,8- 057117-41-6
PENTACHLORODIBENZOFURAN.
1,2,3,4,7,8,9- 055673-89-7
HEPTACHLORODIBENZOFURAN.
68.................... TRICHLOROETHANE................. 025323-89-1
69.................... HEXACHLOROCYCLOPENTADIENE....... 000077-47-4
70.................... 1,2-DIPHENYLHYDRAZINE........... 000122-66-7
71.................... NANOMATERIALS................... ..............
72.................... VANADIUM........................ 007440-62-2
73.................... FORMALDEHYDE.................... 000050-00-0
------------------------------------------------------------------------
(1) Various.
[[Page 60677]]
Submission of Nominations for the Evaluation Set 22
Proposed Substances: Today's notice also invites voluntary public
nominations for substances not listed in this notice. Nominations are
most useful if they include the nominator, including full name, title,
affiliation, email address, and telephone number.
ATSDR will evaluate all data and information associated with
nominated substances and will determine the final list of substances
that will be chosen for toxicological profile development. Substances
will be chosen according to ATSDR's specific guidelines for selection,
found in the Selection Criteria announced in the Federal Register on
May 7th, 1993 (87 FR 27288).
Please submit nominations by one of the following methods:
E-mail: jxt1@cdc.gov.
Fax: 770.488.4178.
Mail: CDR Jessilynn Taylor, 1600 Clifton Rd, NE., MS F32,
Atlanta, GA, 30333.
Please ensure that your comments are submitted within the specified
nomination period. Nominations received after the closing date will be
marked as late and may be considered only if time permits.
Dated: October 19, 2007.
Ken Rose,
Director, Office of Policy, Planning and Evaluation, National Center
for Environmental Health/Agency for Toxic Substances and Disease
Registry.
[FR Doc. E7-21018 Filed 10-24-07; 8:45 am]
BILLING CODE 4163-70-P
